AGM/EGMJun 5, 2026, 04:32 PM
NovoCure Shareholders Elect 11 Directors, Approve Incentive Plan
AI Summary
NovoCure Limited held its Annual General Meeting on June 3, 2026, where shareholders elected eleven directors to serve until the 2027 annual meeting. Key proposals approved included the ratification of Kost Forer Gabbay & Kasierer as the independent auditor for 2026, a non-binding advisory vote on executive compensation, and the Company's Amended and Restated 2024 Omnibus Incentive Plan. Approximately 81.01% of total shares entitled to vote were present and voted on the proposals.
Key Highlights
- NovoCure shareholders elected 11 directors, including Asaf Danziger and William Doyle, to serve until the 2027 annual meeting.
- The appointment of Kost Forer Gabbay & Kasierer as the independent auditor for 2026 was ratified with 91,436,910 votes For.
- A non-binding advisory vote to approve executive compensation was approved with 75,392,168 votes For.
- The Company's Amended and Restated 2024 Omnibus Incentive Plan was approved with 41,680,622 votes For.
- Approximately 81.01% of total shares entitled to vote were present at the Annual Meeting.
Price Impact
More from NVCR